Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Weill Cornell Medical College
Biotech
Eli Lilly-backed IpiNovyx Bio snags $10M for 2023 clinical entry
Backed by Eli Lilly and based on science out of Weill Cornell Medicine, IpiNovyx Bio is emerging with $10 million to get into clinical trials in 2023.
Kyle LaHucik
Oct 5, 2021 7:00am
Cleerly launches with $43M to bring AI imaging to heart disease
Jun 21, 2021 11:45am
Deploying gene therapy against diabetes, Alzheimer's and more
Mar 30, 2021 7:00am
XyloCor bags $23M to expand heart disease gene therapy R&D
Mar 22, 2021 9:20am
XPrize names winners of $6M COVID diagnostics competition
Mar 16, 2021 12:22pm
Lexeo Therapeutics emerges with $85M, 18 gene therapy programs
Jan 7, 2021 7:30am
